Maryland Medical Assistance Program - Supplemental Rebate Program - Subscription Model for Hepatitis C Therapies
What this bill does
Requiring, on or before December 1, 2021, the Maryland Department of Health to apply to the Centers for Medicare and Medicaid Services for a State plan amendment that authorizes the State to enter into value-based arrangements with drug manufacturers through supplemental rebate agreements and seeks an approval that authorizes a subscription model for hepatitis C therapies; requiring, to the extent possible, the Maryland Department of Health, in collaboration certain other State agencies, to develop a certain subscription model; etc.
Analysis reads the bill text, the fiscal note, and the witness list. It is generated by Claude and reviewed by nobody, so check the source documents before you rely on it.
Testimony (6)
MGA witness list| Position | Witness | Organization | Testimony |
|---|---|---|---|
| FAV | Delegate Hill, Delegate Hilllegislator | Individual | Oral |
| UNF | Briemann, Jenniferlobbyist | Individual | Written (PDF) |
| FWA | Hill, Terri | Individual | Written (PDF) |
| INFO | Taylor, Allisonlobbyist | Kaiser Permanente | Oral + Written (PDF) |
| INFO | Bennardi, Maryland Department of Health /Office of Governmen | Maryland Dept. of Health | Written (PDF) |
| INFO | Kasemeyer, Pam | Schwartz, Metz & Wise, P.A. | Written (PDF) |